We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Shire Ads Rep 3 | LSE:0L60 | London | Ordinary Share | SHIRE ADR REPRESENTING 3 ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 168.95 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSHP
RNS Number : 3063S
JPMorgan Securities Plc
22 June 2018
AMMENT
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
Hot Features
Premium
1. KEY INFORMATION
(a) Name of exempt principal trader: J.P. Morgan Securities Plc
(b) Name of offeror/offeree in relation to whose relevant Shire plc
securities this form relates:
Use a separate form for each offeror/offeree
----------------------------------------------------------
(c) Name of the party to the offer with which exempt Joint Financial Adviser to Takeda Pharmaceutical Company
principal trader is connected: Limited
----------------------------------------------------------
(d) Date dealing undertaken: 15 June 2018
----------------------------------------------------------
(e) In addition to the company in 1(b) above, is the Yes, Takeda Pharmaceutical Company Limited
exempt principal trader making disclosures
in respect of any other party to this offer?
If it is a cash offer or possible cash offer, state "N/A"
----------------------------------------------------------
2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchases/ sales Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
(GBP) (GBP)
Ordinary Shares Purchases 671,357 40.9950 38.0000
Sales 593,148 42.0000 40.3732
----------------- ------------------------ ----------------------- -----------------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
Ordinary Shares Equity Swaps Long 13,657 40.3724
453 40.3732
4,890 40.3750
4,271 40.4771
1,596 40.5161
333 40.6098
24,570 40.6943
116 40.6988
546 40.7581
49 40.7688
189 40.7694
231 40.7828
686 40.7928
249,759 40.8000
279,998 40.8459
Short 2,108 40.3750
17 40.3762
15,645 40.3768
2,661 40.6131
116 40.6191
11,092 40.6724
232 40.7212
74 40.7675
1,827 40.7789
1,426 40.7894
117 40.8450
491 40.8540
1,069 40.8541
610 40.8995
228,000 40.9000
1,316 40.9452
-------------------- ------------------------- ------------------------- ---------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option (GBP) European unit
relates etc. (GBP)
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
(GBP)
Ordinary Shares Call Option Exercising 10,000 38.00
Put Option Exercising 14,600 42.00
-------------------- ----------------------- --------------------- -----------------------
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable) (GBP)
e.g. subscription, conversion
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt
principal trader making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
Date of disclosure: 22 June 2018
Contact name: Alwyn Basch
--------------
Telephone number: 020 7742 7407
--------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
FERLLFVERLIFFIT
(END) Dow Jones Newswires
June 22, 2018 11:32 ET (15:32 GMT)
1 Year Shire Ads Rep 3 Chart |
1 Month Shire Ads Rep 3 Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
